What Causes Herpes Outbreaks? CBCD Reviews the Medical Information

“Are you infected with a herpes virus? The CBCD recommends taking Novirin or Gene-Eden-VIR.” – Greg Bennett, CBCD

Recurrent herpes outbreaks occur when the latent virus reactivates and begins to multiply. Dr. Stephen Tyring and colleagues wrote in a study that “recurrent genital herpes outbreaks are predominantly caused by herpes simplex virus type 2 (HSV-2), although the incidence of genital herpes caused by herpes simplex virus type 1 (HSV-1) is rising due to changing attitudes about oral-genital sexual behavior. Approximately one in four adults in the United States is seropositive (that is, infected with) HSV-2, an incurable infection that initially enters the body through mucous membranes or abraded (broken) skin. Once primary infection has occurred, the virus remains dormant in the dorsal root ganglia (a set of nerves), where it can reactivate to cause uncomfortable, recurrent outbreaks.” (1) Dr. Tyring and colleagues are from the Department of Dermatology, Microbiology and Molecular Genetics and Internal Medicine at the University of Texas Health Science Center.

The CBCD points out that reactivation of the herpes virus may be symptomatic or asymptomatic. In other words, there might be visible symptoms or not. Due to the nature and structure of the nervous system, recurrences of herpes may not always appear in the same exact place. In fact, the herpes virus may cause an outbreak in another location associated with the same nerve that supplies the original site of infection. For example, in genital Herpes infections, the outbreak may migrate a few inches “showing up on the upper thigh, or the buttocks. Many times, genital herpes outbreaks appear in the anal region.” (2) Some people have recurrent outbreaks with the so-called “classic” blister-like herpes lesions that crust over, or with painful sores. However, “in some studies, people with herpes were completely unaware of lesions about one-third of the time that the virus was found to be active in the genital area. While recognizing lesions and other symptoms is important, this cannot always tell you when the virus is active.” (3) Thus, the CBCD recommends that individuals infected with the herpes virus take Novirin or Gene-Eden-VIR to help their immune system target the virus in its latent form, before it has the opportunity to reactivate.

Click to learn more about herpes symptoms.

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs.  Study authors wrote that, “individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4)  The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

“The number of outbreaks someone has varies from person to person. The average number of outbreaks for a person with genital HSV-2 is four to five per year. The average for genital HSV-1 is less than one outbreak per year.” (3)

What treatments are available for a recurrent herpes infection?

“Although there is no cure for HSV-2 infection, patients have two treatment options: treating outbreaks as they occur (episodic therapy), or attempting to prevent future outbreaks (suppressive therapy).” (1)

Additionally, it should be noted that “two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (4) There are also natural remedies that target the latent HSV. Two of these clinically backed remedies are Novirin and Gene-Eden-VIR.

In light of the above information, the CBCD recommends that individuals infected with the herpes virus (HSV-1 or HSV-2) take Novirin or Gene-Eden-VIR.

Click to read more about Novirin and the herpes virus, or Gene-Eden-VIR and the herpes virus.

References:

(1)   Tyring S1, Richwald G, Hamed K. Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes. Arch Gynecol Obstet. 2007 Jan;275(1):1-3.

(2)   herpesite.org – Recurrences and Outbreaks.

(3)   Asha – American Sexual Health Association – Signs & Symptoms – The First Episode.

(4)   Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.